Acetadote

Acetadote is a brand name of acetylcysteine, approved by the FDA in the following formulation(s):

ACETADOTE (acetylcysteine - injectable; intravenous)

• 
  Manufacturer: CUMBERLAND PHARMS
  
  Approval date: January 23, 2004
  
  Strength(s): 6GM/30ML (200MG/ML) ^[RLD]

Has a generic version of Acetadote been approved?

No. There is currently no therapeutically equivalent version of Acetadote available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Acetadote. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Acetadote.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • January 23, 2011 - ORPHAN DRUG EXCLUSIVITY
  
  

See also...

• Acetadote Consumer Information (Drugs.com)
• Acetylcysteine Solution Consumer Information (Wolters Kluwer)
• Acetylcysteine inhalation Consumer Information (Cerner Multum)
• Acetylcysteine Inhalation, oral/nebulization Advanced Consumer Information (Micromedex)
• Acetylcysteine AHFS DI Monographs (ASHP)